• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, April 6, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bibliometric Mapping Uncovers the Evolution of Glioma Classification Research

Bioengineer by Bioengineer
April 6, 2026
in Biology
Reading Time: 4 mins read
0
Bibliometric Mapping Uncovers the Evolution of Glioma Classification Research
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A groundbreaking bibliometric study has emerged from the collaborative efforts led by Kayode Ahmed of The University of Texas MD Anderson Cancer Center and Juan E. Núñez-Ríos from Universidad Panamericana, revealing a comprehensive mapping of glioma classification research. Published recently in Volume 17 of the journal Oncotarget, this insightful literature review harnesses advanced network analysis methodologies to decode the evolution and thematic focus of glioma classification studies from a multidimensional lens encompassing clinical, molecular, and social domains.

The research team employed a sophisticated bibliometric approach grounded in direct citation network analysis, involving an expansive dataset retrieved from the Web of Science. Comprising over 46,000 academic documents connected through more than 230,000 citation arcs, this network enabled the unraveling of pivotal scientific contributions and intellectual trajectories that have shaped the field over time. The use of main path analysis alongside key route and K-core methodologies assisted in isolating not only influential publications but also critical thematic clusters defining this research frontier.

One of the most significant outcomes of the study is the identification of DNA methylation profiling as a central pillar in the molecular classification models of gliomas. DNA methylation, an epigenetic modification influencing gene expression without altering the DNA sequence, has increasingly served as a biomarker facilitating higher-resolution subclassifications of glioma tumors. This molecular hallmark is now recognized for its diagnostic and prognostic prowess, driving personalized therapeutic strategies and refining the World Health Organization’s glioma classification framework.

Simultaneously, the bibliometric analysis underlines the critical role advanced neuroimaging technologies have played in the field. Enhanced imaging modalities, such as multiparametric MRI and PET scans, complement molecular profiling by providing spatial and functional tumor characterizations, thereby enabling more precise, non-invasive diagnostic pathways. This multidisciplinary integration of molecular data and imaging signatures encapsulates the progressive sophistication defining contemporary glioma research.

Intriguingly, despite the evident clinical and molecular advances, the review exposes a conspicuous paucity of studies incorporating social factors within glioma classification research. Social determinants of health—encompassing socioeconomic status, environmental exposures, and healthcare accessibility—remain underexplored in this domain. This thematic gap highlights a critical frontier for future research, suggesting that integrative models embedding socio-clinical contexts could substantially enrich patient stratification and outcome prediction frameworks.

The authors advocate that the analytical framework they applied transcends traditional bibliometric indicators like citation counts or h-indices, which often provide an incomplete picture of scientific development. Instead, their approach discerns the evolutionary logic and network architecture underlying the glioma research landscape, capturing complex interdependencies and thematic evolution with enhanced granularity. Such comprehensive mapping is invaluable for researchers and clinicians aiming to navigate this rapidly expanding knowledge ecosystem.

Moreover, the k-core analysis employed to examine densely interconnected subgraphs within the network offers a novel perspective on intellectual clusters—groups of publications that are tightly interlinked by shared themes or methodologies. This technique elucidates the core structure of glioma research, providing a clearer understanding of dominant scientific schools of thought and collaborative networks that sustain them.

By integrating multiple bibliometric techniques, the study not only reconstructs the historical progression and influential research nodes in glioma classification but also anticipates emerging trends. This foresight is crucial for funding agencies, policymaking bodies, and research institutions intending to prioritize areas with high translational potential and unmet clinical needs.

The study’s identification of molecular biomarkers such as DNA methylation profiling, alongside imaging advancements, reaffirms their synergistic impact in propelling precision oncology. Yet, the highlighted deficiency of social determinant considerations calls for interdisciplinary efforts that bridge molecular oncology with public health and social sciences, potentially opening new avenues for holistic patient care approaches.

Ahmed and Núñez-Ríos’ work represents a paradigm shift in how glioma classification research is analyzed and understood. By providing a multidimensional, data-driven narrative of this complex scientific arena, it encourages a more integrative research ethos—one that blends clinical insight, molecular innovation, and sociological awareness to ultimately improve glioma patient outcomes.

In conclusion, this bibliometric mapping underscores the imperative to embrace a broader research paradigm, inviting stakeholders to recognize the multifaceted nature of glioma classification. The promise lies in future models that harmonize molecular and imaging data with social determinants, ensuring that classification systems better reflect the diversity and complexity of real-world patient populations, thereby optimizing precision medicine strategies.

For scientists and clinicians alike, this study offers a clarion call: to harness network analytics not merely as retrospective tools but as proactive instruments shaping the trajectory of cancer research. The integration of big data bibliometrics with domain expertise stands to transform glioma research, fostering innovation that can ultimately translate into tangible clinical breakthroughs.

Subject of Research:
Not applicable

Article Title:
Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses

News Publication Date:
31-Mar-2026

Web References:
https://doi.org/10.18632/oncotarget.28851

References:
[62] Referenced within the figure caption in the original source.

Image Credits:
Copyright: © 2026 Ahmed and Núñez-Ríos. Distributed under the Creative Commons Attribution License (CC BY 4.0).

Keywords:
cancer, glioma research, social network analysis, socio-clinical domains, web of science, networks

Tags: bibliometric mapping of glioma studiescancer epigenetics in gliomascitation network analysis in oncologyclinical and molecular glioma studiesDNA methylation profiling in gliomasevolution of glioma researchglioma classification researchmain path analysis in bibliometricsmolecular classification of brain tumorsmultidisciplinary approach to glioma classificationnetwork analysis in scientific researchthematic clusters in glioma research

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

New Tool Developed to Predict CRRT Risk and Enhance Early AKI Management After Lung Transplantation

April 6, 2026
How Mitochondrial DNA Influences Your Health: What Science Reveals

How Mitochondrial DNA Influences Your Health: What Science Reveals

April 6, 2026

Why Cats Stop Eating — It’s More Than Just Feeling Full

April 6, 2026

New Study in The Crop Journal Unveils Pathogen-Inducible Gene Expression Strategy to Overcome Resistance-Yield Trade-off in Rice

April 6, 2026

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1009 shares
    Share 399 Tweet 249
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cognitive Changes Over Time in Parkinson’s Disease

Bioabsorbable Si-Mg Cells Boost Nerve Regeneration

Boosting Breast Cancer Risk Prediction with Genetics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.